374 filings
Page 9 of 19
10-K
2016 FY
THER
Theralink Technologies, Inc.
Annual report
17 Apr 17
12:00am
NT 10-K
THER
Theralink Technologies, Inc.
3 Apr 17
Notice of late annual filing
12:00am
NT 10-K/A
THER
Theralink Technologies, Inc.
3 Apr 17
Notice of late annual filing (amended)
12:00am
8-K/A
THER
Theralink Technologies, Inc.
31 Mar 17
Financial Statements and Exhibits
12:00am
SC 13D
THER
Theralink Technologies, Inc.
20 Mar 17
OncBioMune Pharmaceuticals, Inc
12:00am
3
THER
Theralink Technologies, Inc.
20 Mar 17
OncBioMune Pharmaceuticals / Manuel Cosme Odabachian ownership change
12:00am
3
Volnie Carlos Fernando Alaman
20 Mar 17
OncBioMune Pharmaceuticals / Carlos Fernando Alaman Volnie ownership change
12:00am
SC 13D
Volnie Carlos Fernando Alaman
20 Mar 17
OncBioMune Pharmaceuticals, Inc
12:00am
4
Head Jonathan Frederick
13 Mar 17
OncBioMune Pharmaceuticals / JONATHAN FREDERICK HEAD ownership change
12:00am
8-K
THER
Theralink Technologies, Inc.
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
THER
Theralink Technologies, Inc.
28 Nov 16
Entry into a Material Definitive Agreement
12:00am
10-Q
2016 Q3
THER
Theralink Technologies, Inc.
Quarterly report
21 Nov 16
12:00am
NT 10-Q
THER
Theralink Technologies, Inc.
15 Nov 16
Notice of late quarterly filing
12:00am
8-K
THER
Theralink Technologies, Inc.
3 Nov 16
Regulation FD Disclosure
12:00am
424B3
THER
Theralink Technologies, Inc.
23 Sep 16
Prospectus supplement
12:00am
EFFECT
THER
Theralink Technologies, Inc.
20 Sep 16
Notice of effectiveness
12:00am
POS AM
THER
Theralink Technologies, Inc.
15 Sep 16
Prospectus update (post-effective amendment)
12:00am
CORRESP
THER
Theralink Technologies, Inc.
15 Sep 16
Correspondence with SEC
12:00am
8-K
THER
Theralink Technologies, Inc.
14 Sep 16
Regulation FD Disclosure
12:00am
UPLOAD
THER
Theralink Technologies, Inc.
6 Sep 16
Letter from SEC
12:00am